Iwamoto, Naoko http://orcid.org/0000-0003-1406-0760
Miyamoto, Hiromi
Horiguchi, Shinichiro
Honda, Yayoi
Aruga, Tomoyuki
Article History
Received: 4 September 2019
Accepted: 17 January 2020
First Online: 29 February 2020
Compliance with ethical standards
:
: T. Aruga has received honoraria from Chugai Pharmaceutical Co., Ltd. and Pfizer Japan Inc. Naoko Iwamoto, Shinichiro Horiguchi, Hiromi Miyamoto, and Yayoi Honda have no conflicts of interest to declare.
: The Institutional Ethics Committee of Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital approved all experimental protocols, and written informed consent was waived because of the retrospective design.